Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
BMJ Open|February 12, 2022
Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson's disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD)Taku Hatano, Genko Oyama, Yasushi Shimo, et al.
Japanese Journal of Ophthalmology|February 15, 2021
Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled studyOsamu Hieda, Takahiro Hiraoka, Takashi Fujikado, et al.
Movement Disorders Clinical Practice|January 16, 2026
Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's DiseaseK Ray Chaudhuri, Bruno Bergmans, Eric Freire-Alvarez, et al.
BMC Neurology|March 4, 2022
Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled studyTaku Hatano, Osamu Kano, Renpei Sengoku, et al.
BMJ Open|October 21, 2025
Randomised, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of antibiotic faecal microbiota transplantation in patients with Parkinson's disease (FLORA-PD): a study protocolHaruka Takeshige-Amano, Eriko Igami, Ayami Okuzumi, et al.
Parkinsonism & Related Disorders|September 16, 2022
Idiopathic rapid eye movement sleep behavior disorder in Japan: An observational studyNoriko Nishikawa, Miho Murata, Taku Hatano, et al.
Scientific Reports|March 15, 2023
Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson's disease in JapanGenko Oyama, Maximilien Burq, Taku Hatano, et al.
Clinical Parkinsonism & Related Disorders|May 5, 2025
Impact of istradefylline on motor and non-motor symptoms in patients with Parkinson's disease: Subanalysis of the ISTRA ADJUST PDHiroshi Nagayama, Osamu Kano, Renpei Sengoku, et al.
Neurology and Therapy|January 16, 2024
Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled StudyTaku Hatano, Renpei Sengoku, Hiroshi Nagayama, et al.
Annals of Neurology|March 19, 2016
Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2Yujiro Higuchi, Akihiro Hashiguchi, Junhui Yuan, et al.
Pageof 11